June 26, 2020
Sosei Group has sealed a pact with AbbVie, which could potentially be worth up to US$1 billion-plus, to discover, develop, and commercialize novel medicines, initially focusing on small molecules targeting the US firm’s priority areas of inflammatory and autoimmune diseases...read more